Kang S, Jeon S, Lee D, et al
APOE4-dependent cholinergic/dopaminergic contributions to clinical symptoms across Alzheimer’s disease spectrum: A retrospective observational study 2026
European Journal of Nuclear Medicine and Molecular Imaging
Kang S, Kim Y, Jeon S, Yun M, Ye BS
Association of plasma lipid levels with Alzheimer’s disease and Lewy body disease biomarkers: a cross-sectional study 2026
Scientific Reports
Lee Y, Kang S, Kim YS, Kim JS, Kim H-J
Regional amyloid PET asymmetry and long-term clinical trajectory in mild cognitive impairment 2026
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Kim S, Jeon S, Cho K, et al
Deep learning for FDG-PET classification in patients with Alzheimer’s disease, dementia with Lewy bodies and their mixed pathology: a solution for diagnostic heterogeneity 2026
Frontiers in Aging Neuroscience
Kang S, Ye BS, Yun M, Lee YG
Effect of tau burden and Lewy pathology on neuropsychiatric symptoms in Aβ-positive individuals 2026
Alzheimer's & Dementia
Kang S, Na HK, Yoon SH, et al
Interplay of age-sensitive cortical vulnerability and dopaminergic degeneration in clinical manifestations of Parkinson’s disease 2026
Neurobiology of Aging
Bolsewig K, Bellomo G, Hok-A-Hin YS, et al
A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disorders 2026
Nature Medicine
Ye BS, Park SH, Jeon S, Kang S, Kim SH, Chang WS
Degenerative pathologies on cortical biopsy, dopaminergic depletion, and shunt efficacy in iNPH 2025
Alzheimer's & Dementia
Ye BS, Chang KW, Kang S, Jeon S, Chang JW
Repetitive and extensive focused ultrasound-mediated bilateral frontal blood-brain barrier opening for Alzheimer's disease 2025
Journal of Neurosurgery
Lee YG, Baik K, Park M, Kang SW, Yoon SH
Subtyping of Parkinson's Disease by Longitudinal Trajectories of Levodopa Equivalent Daily Dose 2025
Journal of Movement Disorders
Lee Y-g, Kang SW, Lee S, Jeon S, Ye BS, Yun M
Clinical Implications of an Integrated Clinical and Biological Staging Scheme for Alzheimer’s Disease 2025
Journal of Clinical Neurology
Lee E, Kang S, Ye BS, Lee Y-g
Adherence of Anti-Dementia Medications in Alzheimer’s Disease and Related Dementia: A Nationwide Cohort Study in Korea 2025
Journal of Korean Medical Science
Kang S, Lee Y, Kim N, et al
Beneficial effect of artificial intelligence care call on memory and depression in community dwelling individuals with dementia 2025
Scientific Reports
Kang S, Jeon S, Lee Y-g, Yun M, Kim H, Ye BS
Brain Perfusion, Atrophy, and Dopaminergic Changes in Amyloid Negative Logopenic Primary Progressive Aphasia 2025
Scientific Reports
Kang S, Jeon S, Kim Y, et al
White matter hyperintensities and cholinergic degeneration as Lewy body disease 2025
Annals of Clinical and Translational Neurology
Kang S, Jeon S, Kim Y, et al
Putaminal hypermetabolism identifies Lewy body co-pathology in Alzheimer's disease 2025
Alzheimer's & Dementia
Baik K, Jeon S, Kang S, et al
Implication of dopamine transporter and electroencephalography biomarkers in dementia with lewy bodies 2025
Scientific Reports
Yoon SH, You DH, Na HK, et al
Parkinson's disease with hyposmia and dysautonomia: does it represent a distinct subtype? 2024
Journal of Neurology
Yoo HS, Kim HK, Na HK, et al
Association of Striatal Dopamine Depletion and Brain Metabolism Changes With Motor and Cognitive Deficits in Patients With Parkinson Disease 2024
Neurology
Yoo HS, Kim HK, Lee HS, et al
Predictors associated with the rate of progression of nigrostriatal degeneration in Parkinson's disease 2024
Journal of Neurology
Na HK, Sohn B, Sun Y, et al
Enlarged perivascular space in the temporal lobe as a predictor for cerebral amyloidosis in Lewy body disease 2024
Parkinsonism & Related Disorders
Kang S, Jeon S, Lee YG, Ye BS
Dopamine transporter positron emission tomography in patients with Alzheimer's disease with Lewy body disease features 2024
Neurobiology of Aging
Kang S, Jeon S, Lee YG, Ye BS
Alteration of medial temporal lobe metabolism related to Alzheimer's disease and dementia with lewy bodies 2024
Alzheimer's Research & Therapy
Lee YG, Yoon SJ, Yoon SH, et al
Air pollution is associated with faster cognitive decline in Alzheimer's disease 2023
Annals of Clinical and Translational Neurology
Lee YG, Park M, Jeong SH, et al
Association of Neuropsychiatric Symptom Profiles With Cognitive Decline in Patients With Parkinson Disease and Mild Cognitive Impairment 2023
Neurology
Lee YG, Jeon S, Kang SW, Ye BS
Effects of amyloid beta and dopaminergic depletion on perfusion and clinical symptoms 2023
Alzheimer's & Dementia
Lee Y-g, Jeon S, Baik K, Kang SW, Ye BS
Substantia nigral dopamine transporter uptake in dementia with Lewy bodies 2023
npj Parkinson's Disease
Kang S, Yoon SH, Na HK, et al
Neuropsychological Comparison of Patients With Alzheimer's Disease and Dementia With Lewy Bodies 2023
Journal of Clinical Neurology
Kang S, Jeon S, Lee YG, Ye BS
Striatal dopamine transporter uptake, parkinsonism and cognition in Alzheimer's disease 2023
European Journal of Neurology
Lee YG, Jeon S, Park M, et al
Effects of Alzheimer and Lewy Body Disease Pathologies on Brain Metabolism 2022
Annals of Neurology
Lee Y-g, Jeong SH, Park M, et al
Effects of Alzheimer’s genetic risk scores and CSF biomarkers in de novo Parkinson’s Disease 2022
npj Parkinson's Disease
Park M, Baik K, Lee YG, et al
Implication of Small Vessel Disease MRI Markers in Alzheimer's Disease and Lewy Body Disease 2021
Journal of Alzheimer's Disease
Lee Y-g, Park M, Jeong SH, et al
Effects of baseline serum uric acid and apolipoprotein E4 on longitudinal cognition and cerebral metabolism 2021
Neurobiology of Aging
Lee YG, Jeon S, Kang SW, et al
Interaction of CSF α-synuclein and amyloid beta in cognition and cortical atrophy 2021
Alzheimer's & Dementia (Amsterdam)
Kang SW, Jeon S, Lee YG, et al
Implication of metabolic and dopamine transporter PET in dementia with Lewy bodies 2021
Scientific Reports
Kang SW, Jeon S, Yoo HS, et al
Effects of Lewy body disease and Alzheimer disease on brain atrophy and cognitive dysfunction 2019
Neurology
Baik M, Kim SU, Kang S, et al
Liver Fibrosis, Not Steatosis, Associates with Long-Term Outcomes in Ischaemic Stroke Patients 2019
Cerebrovascular Diseases